Patients with cancer are at an increased risk for SARS-CoV-2 infection and severe COVID-19 because of the lowered immunity associated with anticancer drugs, radiation therapy, and cancer itself, as well as increased exposure due to frequent visits to the hospital.
Read more about Immunotherapy after bladder cancer surgery may reduce recurrence: Study on Business Standard. Researchers at the Memorial Sloan Kettering Cancer Center found that patients who received nivolumab after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence